RRC ID 86399
著者 Yasukochi S, Yamakawa W, Taniguchi M, Itoyama S, Tsuruta A, Kusunose N, Yamauchi T, Nakamura R, Matsunaga N, Ohdo S, Koyanagi S.
タイトル The Circadian Clock Component REV-ERB Is an Analgesic Target for Cancer-Induced Tactile Pain Hypersensitivity.
ジャーナル J Neurosci
Abstract Neuropathic pain is one of the most intractable pain conditions associated with tumor growth compressing and damaging nerves. A troublesome hallmark symptom of neuropathic pain is hypersensitivity to innocuous stimuli, known as "tactile allodynia," which is often refractory to currently available analgesics. Diurnal variations in pain hypersensitivity are common in patients with cancer, but the underlying mechanisms are enigmatic. Herein, we report that spinal expression of lipocalin-2 (LCN2) enhances pain sensitivity of NCTC2472 fibrosarcoma-implanted male mice during specific stages of the diurnal cycle. As the tumor grew, interleukin-6 (IL-6) levels increased in the spinal cord of the mice. Increased IL-6 levels stimulated LCN2 expression in spinal microglia, but this expression was periodically repressed by the circadian clock components REV-ERBα and REV-ERBβ. Notably, intraspinal dorsal horn injection of lentiviral vectors expressing REV-ERBα or REV-ERBβ in tumor-bearing mice alleviated tactile allodynia. Furthermore, intrathecal injection of SR9009, a synthetic agonist of REV-ERBs, also attenuated cancer-induced pain hypersensitivity, accompanied by suppressing spinal LCN2 expression. These results suggest that temporal elevation of LCN2 expression decreases the threshold of tactile pain hypersensitivity induced by tumor growth. We propose that the circadian clock component of REV-ERBs is an effective target for alleviation of cancer-induced tactile allodynia, identifying a new class of analgesic agents.
巻・号 45(22)
公開日 2025-5-28
DOI 10.1523/JNEUROSCI.1969-24.2025
PII JNEUROSCI.1969-24.2025
PMID 40268481
PMC PMC12121715
MeSH Analgesics* / pharmacology Analgesics* / therapeutic use Animals Cancer Pain* / drug therapy Cancer Pain* / metabolism Cell Line, Tumor Circadian Clocks* / drug effects Circadian Clocks* / physiology Hyperalgesia* / drug therapy Hyperalgesia* / etiology Hyperalgesia* / metabolism Lipocalin-2 / metabolism Male Mice Mice, Inbred C57BL Nuclear Receptor Subfamily 1, Group D, Member 1* / agonists Nuclear Receptor Subfamily 1, Group D, Member 1* / genetics Nuclear Receptor Subfamily 1, Group D, Member 1* / metabolism Pyrrolidines / pharmacology Receptors, Cytoplasmic and Nuclear Repressor Proteins Spinal Cord / metabolism Thiophenes / pharmacology Thiophenes / therapeutic use
IF 5.674
リソース情報
ヒト・動物細胞 MG6(RCB2403)